General MedicationsORALStandard
VIREAD
TENOFOVIR DISOPROXIL FUMARATE
Standard Dose
40MG/SCOOPFUL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview VIREAD is listed in Drugs@FDA under application 022577 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TENOFOVIR DISOPROXIL FUMARATE Form and strength POWDER;ORAL - 40MG/SCOOPFUL Sponsor GILEAD SCIENCES INC Submission history Latest submission status date: 2019-04-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview VIREAD is listed in Drugs@FDA under application 022577 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TENOFOVIR DISOPROXIL FUMARATE Form and strength POWDER;ORAL - 40MG/SCOOPFUL Sponsor GILEAD SCIENCES INC Submission history Latest submission status date: 2019-04-24 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.